ARCA Biopharma Inc (NASDAQ:ABIO)

1.15
Data as of Oct 17
 +0.02 / +1.77%
Today’s Change
1.09
Today|||52-Week Range
2.54
-31.55%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$24.2M

Company Description

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. ARCA biopharma was founded in 1992 and is headquartered in Westminster, CO.

Contact Information

ARCA biopharma, Inc.
11080 CirclePoint Road
Westminster Colorado 80020
P:(720) 940-2100
Investor Relations:
(720) 940-2163

Employees

Shareholders

Mutual fund holders2.70%
Other institutional2.08%
Individual stakeholders18.38%

Top Executives

Michael R. BristowPresident, Chief Executive Officer & Director
Patrick M. WheelerChief Financial Officer
Gordon DavisVice President-Clinical Information Systems
Christopher David OzeroffSecretary, Senior Vice President & General Counsel
Derek K. ColeVice President-Investor Relations & Communications

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.